Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Arcutis Biotherapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arcutis Biotherapeutics Inc. June 5, 202667.4%
-
MBX Biosciences Inc. June 4, 202688.4%
-
Mirum Pharmaceuticals Inc. June 5, 202471.8%
-
Arcutis Biotherapeutics Inc. June 2, 202386.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Arcutis Biotherapeutics Inc. | Grant or award | +5,778 | — | — |
| Jan 23, 2026 | Mirum Pharmaceuticals Inc. | Other | +159,277 | — | — |
| Jan 23, 2026 | Mirum Pharmaceuticals Inc. | Open-market purchase | +131,425 | $68.48 | $8,999,984 |
| Sep 26, 2025 | MBX Biosciences Inc. | Open-market purchase | +666,666 | $18.00 | $11,999,988 |
| Jun 13, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +2,646 | $13.08 | $34,610 |
| Jun 12, 2025 | Arcutis Biotherapeutics Inc. | Grant or award | +7,609 | — | — |
| Jun 5, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +378 | $13.41 | $5,069 |
| Jun 4, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +1,890 | $13.32 | $25,175 |
| May 29, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +5,703 | — | — |
| May 22, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +2,520 | $13.65 | $34,398 |
| May 21, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +2,520 | $13.66 | $34,423 |
| May 15, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +2,520 | $13.62 | $34,322 |
| May 14, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +6,300 | $13.76 | $86,688 |
| May 13, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +2,374 | $13.76 | $32,666 |
| May 9, 2025 | Arcutis Biotherapeutics Inc. | Open-market purchase | +6,300 | $13.60 | $85,680 |
Questions about Patrick J. Heron
What boards is Patrick J. Heron on?
Patrick J. Heron sits on the boards of Arcutis Biotherapeutics Inc., MBX Biosciences Inc. and Mirum Pharmaceuticals Inc.
How long has Patrick J. Heron served on boards?
Our records show at least 9 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.